To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The selected vendor "will ...
STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration with Alida ...
This May, TechUK is convening a four-part workshop series designed to support the successful implementation of DSIT's Trusted ...
This April, techUK is launching an essential four-part webinar series followed by a whitepaper exploring the role of AI ...
New cross-sector initiative unites tech, ecology, and policy to shape how artificial intelligence supports nature ...
Providers of modular, behind-the-meter power generation are gaining a substantial foothold in the race to energize large load ...
Jaewon Hur (Seoul National University), Juheon Yi (Nokia Bell Labs, Cambridge, UK), Cheolwoo Myung (Seoul National University), Sangyun Kim (Seoul National University), Youngki Lee (Seoul National ...
Partnership pairs Datavault AI’s patented DataValue®, DataScore® and Information Data Exchange® (IDE®) solutions with Available Infrastructure’s SanQtum™ cybersecure high performance points of ...
Stacker on MSN
Cheapest gas stations in every state Dec. 30, 2025
Anyone who drives a car understands the sting of having to fill up their tank and pulling into the gas station, only to ...
ARTBIO, Inc. ("ARTBIO"), a clinical-stage radiopharmaceutical company developing a new class of 212Pb alpha radioligand therapies (ARTs), announced the appointment of Jonathan Freeman, Ph.D. as Chief ...
OSAKA, Japan & CAMBRIDGE, Mass. & NEWARK, Calif., January 05, 2026--Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics (Nasdaq: PTGX) ("Protagonist") announced the submission of a New Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback